Table 1.
Changes in FSFI scores and laboratory parameters after 12-month combination therapy in Female patients
| Baseline (N = 12) | End of study (N = 10) | 95 % confidence interval of the diff (N = 10) | P value | ||
|---|---|---|---|---|---|
| Lower | Upper | ||||
| FSFI Domains Desire | 5.6 ± 0.9 | 5.5 ± 1.0 | −0.9 | 0.6 | 0.468 |
| Arousal | 2.6 ± 1.9 | 4.6 ± 1.8 | 0.6 | 4.0 | 0.002* |
| Lubrication | 2.3 ± 1.9 | 3.3 ± 2.0 | −0.8 | 3.3 | 0.084 |
| Orgasm | 2.3 ± 1.9 | 3.5 ± 2.1 | −0.6 | 3.4 | 0.050* |
| Satisfaction | 2.4 ± 1.2 | 3.2 ± 2.0 | −0.6 | 2.1 | 0.112 |
| Pain | 2.0 ± 1.6 | 3.8 ± 2.4 | −0.7 | 4.8 | 0.046* |
| Total FSFI score | 17.1 ± 7.2 | 23.7 ± 7.2 | 1.5 | 13.6 | 0.003* |
| FSH (IU/L) | 12.38 ± 13.47 | 33.20 ± 28.75 | 4.45 | 61.95 | 0.067 |
| LH (IU/L) | 8.05 ± 9.09 | 17.26 ± 18.81 | −1.55 | 36.07 | 0.017* |
| E2 (pg/mL) | 81.92 ± 62.62 | 59.50 ± 92.79 | −93.99 | 113.69 | 0.771 |
| VEGF (pg/mL) | 6190.5 ± 3979.3 | 1468.2 ± 1495.4 | 908.7 | 8871.7 | 0.004* |
SD standard deviation